chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient is an 11-year-old  female who received the COVID-19 Pfizer vaccine on 8/12/2021. At this time, there are no reported symptoms by the patient or guardian.
Approximately equal to 2 hours after eye and cheek swelling. No dyspnea, no vomiting.
Had first dose 4/16/21 and second does 12/03/21, third dose given 2/23/22, earlier than the 5 months required.
Leg has a hard and reddened area (3" diameter) and hot to touch. No fever.
Onset of rash 3pm 1/31/2006, itchy back, neck, arms on 2/1/2006. Some lesions are flat red, some raised, 2 with vesicles, 20 above right ear, torso, anterior and posterior, largest lesions on shoulder, vomiting and fever.
pt exp tingling in 3,4,5th finger, up right arm to shoulder,down right side to toes; rx w/ acetaminophen
Pain and swelling to left deltoid area. Left upper arm tricep/bicep area with redness and swelling.  Spoke with patient today she states that her arm is better and pain has stopped.Pt. evaluated at urgent care center she states she was prescribed doxyclycline and naprosyn.
1:55 pm Swelling of gums, fingers, face, throat, lips Difficulty breathing  2:08 pm Given 50 mg IM Benedryl in Right Arm on site  2:32 pm fullness in throat started to subside. 3:00 pm went toEmergency Room for continuing breathing issues. Treated with IV Prednisone, Pepsid and fluids. Before hour was up, throat started to close again. Given Benedryl. Released from ER approximately 7 pm. Still having serious breathing issues but told that I seemed stable and to return if they got worse. Have continued to have issues with breathing and swelling of eyes, lips, face, hands and feet every day since (currently day 12 post vaccine).  Had serious breathing problems 03/09/2021. Was taken toEmergency Room at 11:30 am.
Received vaccines at approximately 7:50AM. While leaving the building about 8:10AM was witnessed by other patients, child fell forward and hit her head on floor. Reported that child lost consciousness for about 1 minute. When staff alerted child was sitting in chair alert and oriented. 911 notified. V/S 78/48, P 78, R 19. Upon EMS arrival mom refused transport to ER. Mom educated on S/S of concussion and head injury precautions.
Tightness in chest; Burning in throat; Legs felt weird; Congestion in ears; Sore Throat; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tightness in chest), THROAT IRRITATION (Burning in throat), FEELING ABNORMAL (Legs felt weird), EAR CONGESTION (Congestion in ears) and OROPHARYNGEAL PAIN (Sore Throat) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Fatty liver since an unknown date and Arm injury. Concurrent medical conditions included Diabetes mellitus, Chronic kidney disease (stage 3 kidney disease.) and Addison's disease. Concomitant products included HYDROCORTISONE ACETATE (CORTES) for Addison's disease, INSULIN for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced CHEST DISCOMFORT (Tightness in chest), THROAT IRRITATION (Burning in throat), FEELING ABNORMAL (Legs felt weird), EAR CONGESTION (Congestion in ears) and OROPHARYNGEAL PAIN (Sore Throat). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Tightness in chest), THROAT IRRITATION (Burning in throat), FEELING ABNORMAL (Legs felt weird), EAR CONGESTION (Congestion in ears) and OROPHARYNGEAL PAIN (Sore Throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was also taking cholesterol medicine. She was treated with Z-pac and Allerga. Treatment medicines were not reported.
Patient experienced numbness and tingling down the arm to the fingers as soon as the vaccine was administered. She is still experiencing the numbness and tingling a day later on the arm that was vaccinated.
pt recvd vax & c/o itching of the soles of both feet;some gen rash of arms & torso were noted late that day or the next morning;
she has a UTI.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (she has a UTI.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (she has a UTI.). At the time of the report, URINARY TRACT INFECTION (she has a UTI.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The UTI was cultured but she does not have the name of the bacteria. She could not tolerate the antibiotic. She took something else that helped, but the UTI has returned.
Myocarditis; This is a spontaneous report from a non-contactable nurse via a Pfizer-sponsored program . An 18-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (batch/lot number was not reported) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was admitted into the hospital with myocarditis after taking the Covid vaccine on an unspecified date. She was wondering when Pfizer would be reaching out to patient's family as it was their vaccine that put the patient into the hospital. Also wondering if Pfizer was tracking this as a side effect. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the available information and known product information, the causal relationship between the reported myocarditis and use of BNT162B2 cannot be fully excluded. There is limited information with regards to medical history and clinical  course  thus precluding a more meaningful assessment. The case will be assessed further upon receipt of additional information.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a health professional concerning a 13-year-old female who in approximately October 2001 was vaccinated with a 0.5mL dose of Varivax. On 29-SEP-2006 the patient developed a full blown case of chickenpox. Unspecified medical attention was sought. Subsequently, the patient recovered from chickenpox on 05-OCT-2006. There was no product quality complaint. Follow up information was received which noted that the health professional who reported the experience was no longer employed with the office and further information could not be provided. Additional information is not expected.
5 hours post vax, the pt experienced emesis and trouble breathing. The pt stopped breathing, mouth to mouth resuscitation was performed and was done when 911 came the pt was breathing. The pt had a fever of 102 and was given IV fluids and antibiotics and was discharged.
My son had a bit of a runny nose on the morning of 11/26/2021. He complained of stomach pain around 4 pm. Around 6 pm he began complaining of severe sore throat, by 7 pm he developed a croup like cough, had swollen lymph nodes and was having trouble breathing.   By about 10 pm his breathing seemed to return to normal but he had the barking type cough throughout the night. On the morning of 11/27/2021 he woke with rosy red cheeks but the cough and breathing issues were gone. He did still have a runny nose and congestion.
Side-effects for first dose - Started menstrual cycle six days early (I have very regular periods)  Side-effects for second dose - Started menstrual cycle five days early + chills, fever, body aches, mild nausea
Chills within 8 hours of shot; fever, nausea, vomiting, chills, body aches started 12 hours after shot lasting for 24 hours
positive home COVID-19 test on; positive home COVID-19 test; This is a spontaneous report received from contactable reporter(s) (Physician and Other HCP).  A 61-year-old female patient received BNT162b2 (BNT162B2), on 28Apr2021 as dose 1, single (Batch/Lot number: unknown) and on 19May2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant) with onset 13Jun2022, outcome "unknown", described as "positive home COVID-19 test"; VACCINATION FAILURE (medically significant) with onset 13Jun2022, outcome "unknown", described as "positive home COVID-19 test on". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (13Jun2022) positive, notes: positive home COVID-19 test. Therapeutic measures were taken as a result of vaccination failure, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the Vaccination failure and Covid -19  cannot be ruled out.
Minor irritation in his injection site arm after each dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE IRRITATION (Minor irritation in his injection site arm after each dose) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE IRRITATION (Minor irritation in his injection site arm after each dose). At the time of the report, VACCINATION SITE IRRITATION (Minor irritation in his injection site arm after each dose) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-546133, MOD-2022-546141 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2022: Non significant follow up received.
I have received my first shot of  (Moderna) in the late evening.  The next day, I started to have soreness, swelling, fever (in my arm) and rash.  Day 2 all side effects started to diminsh. Starting on day 3 and for the next 4 days the swelling, rash, fever (in my arm) progressed.  By day 6 all the side effects were gone.  Then on Sunday, Feburary 7, 2021 at 10:15 p.m., the rash came back (now very red) and covers my whole upper left arm.   My arm is swollen and is very feverish.   I have put a cold pack on my arm 3 x a day, the swelling has gone down, but the rash and fever is persistant.
Information has been received from a physician concerning an 18 year old male who on 08-FEB-1993 was vaccinated with the first dose of MMR II (route, site and lot number not reported). On 21-JUL-1999, the patient was vaccinated with the second dose of MMR II (route, site and lot number not reported). On 30-NOV-2009 the patient experienced mumps (date diagnosed was reported as 03-DEC-2009). The patient was afebrile and had orchitis and body ache. On 03-DEC-2009, the laboratory tests showed serum amylase test 122, serum immunoglobulin G test 2.53 and serum immunoglobulin M test <1:10. The outcome for mumps was not reported. Follow up information has been received concerning the 18 year old male patient who on 11-JAN-2010 (previously reported as 30-NOV-2009) experienced mumps. On 14-JAN-2010 (previously reported as 03-DEC-2010), the patient was diagnosed with mumps. It was noted that the patient developed orchitis for three days. At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Called 9-2-04, arm was red and swollen to elbow. Patient rubbed Benadryl cream on site. Improvement was noted on 9-3-04. Resolved in a few days
So in January I got COVID 19, started with runny nose and a very sore throat and a congested cough that lasted about 5 days.
Pain in left arm for 5 days. Pain in lymph nodes under left arm going into the breast tissue starting on the second day. Tiredness, severe headache unrelieved by Tylenol for 2 days, chills, fever, joint pain, nausea.
Dizziness, nausea, chills, headache, fever, vomiting, diarrhea, fatigue 24 hours from time of vaccine
This is a spontaneous report from a contactable pharmacist. A 71 years old female patient received first dose of PREVNAR 13 (lot number J23864, expiration date Nov2015; NDC: 00005-1971-02) at 0.5 single, on 23Oct2014, at approximately 1 P.M., in left upper arm, back part. On 07Oct2014 the patient received first dose of FLUCELVAX (lot number 016011A, expiration date Mar2015, NDC 62577061311) at 1 DF single, intramuscular, in left upper arm. Adverse event following prior vaccination: no per reporter. Medical history included rheumatoid arthritis. Concomitant medications included pravastatin oral tablet, for cholesterol, at 20 mg once daily, atenolol oral tablet, for blood pressure, at 100 mg twice daily, folic acid, 2 tablets of 1 mg once a day. On an unspecified date in Oct2014 the patient experienced injection site is painful and injection site warm. Furthermore the reporter stated that suspect injection received on 23Oct2014 may have been given subcutaneously. The events did not require an emergency room or doctor visit. The patient stated she had rheumatoid arthritis and had stronger reactions. Events "injection site warm" and "injection site painful" were persisting at time of report. Event suspect injection may have been given subcutaneously outcome was unknown at time of report. Follow-up (04Dec2014): Follow-up attempts completed. No further information expected.
Vaccine received 4/7/2020. On Wednesday 4/14/2020, pt went to the gym and did high intensity interval training involving body weight exercises, specifically an exercise called "v-ups". Exercise was not more strenuous than usual, and pt was well hydrated. Pt reports that she exercises often and this was not a new exercise. Soon after workout, pt began having muscular pain in the hip, radiating into her inner thighs bilaterally with associated tingling. On 4/15, pain worsened and pt had difficulty ambulating. Denies any edema, erythema in her legs or unilateral leg swelling. Presented to the ED on 4/16 and found to have elevated CK of 127,768 with UA significant for large blood and protein, without RBC, indicative of rhabdomyolysis. Pt did not have any known risk factors that may precipitate rhabdomyolysis. On admission, fluids were initiated with downtrending CK, LFTs, and renal function remained stable.   er D&C was done at on 4/2 and she reports there were no complications during or after the procedure. Her BHCG was elevated at the time and she tried an oral abortion pill but still had some fetal remnants so went for a D&C. She had the J&J vaccine shortly after on 4/7 and she reports no complications around and shortly after getting the vaccine. Denies vaginal bleeding or odor. Denies fevers, chills, abd pain, diarrhea, constipation, dysuria, chest pain, palpitations, shortness of breath, nausea/vomiting.
Patient developed erythema at the site of the shots, patient also had blotchy erythema on other parts of body, continued to evolve into erythema with hives, no respiratory difficulty.
Patient received flu vaccination in right deltoid.  Stated after about an hour had stroke like symtpoms that started.  Went to the ED (Patient works in a hospital setting).  Described to ED phys as having an acute onset of right sided numbness. Also, tremulous, and anxious.  Denies weakness of side. Pmhx of similar episodes with not related to vaccines. In the ED- patient appears in a sinus tach through EKG tracing.  Labs- Essentially negative.  BUN 26, CO2-20 Anion Gap 17.   Patient also had MRI with negative results of stroke.
Experiencing fatigue, chills, body aches and headache. Gave IB and had him drink more water. Went to bed early.  Woke up still with same symptoms.
fever; woke up nauseated; head hurt; This case was reported by a consumer via call center representative and described the occurrence of headache in a 11-year-old female patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis.   Co-suspect products included MENINGOCOCCAL VACCINE for prophylaxis.   On 30th November 2021, the patient received Tdap Vaccine and MENINGOCOCCAL VACCINE. On 1st December 2021, 1 days after receiving Tdap Vaccine, the patient experienced headache. On 2nd December 2021, the patient experienced fever and nausea. On an unknown date, the outcome of the headache, fever and nausea were unknown.   It was unknown if the reporter considered the headache, fever and nausea to be related to Tdap Vaccine.  Additional details were reported as follows: The case was reported by the patient's mother. The patient received unspecified meningitis and Tdap vaccines.  The reporter was unsure if the meningitis was serotype B or serotype A, C, W and Y, due to limitation in company dictionary coded as WHO DD Dictionary.  Reporter did not have lot numbers or brand names of the products administered. On 1st December 2021, the patient's head hurt (headache). On 2nd December 2021, the patient woke up nauseated and had a fever.  No further information gathered. Reporter going to contact pediatric office to obtain the names of the vaccines administered. The reporter consented to follow up.
suspected vaccination failure; mild case near eye; Rash; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), herpes zoster and rash. The patient was treated with antivirals nos. On an unknown date, the outcome of the vaccination failure, herpes zoster and rash were unknown.   It was unknown if the reporter considered the vaccination failure, herpes zoster and rash to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's wife. The reporter stated that her 90 year old father had shingles and it was brutal. He was frail but doing ok. The patient had the Shingles vaccine and he got a very mild case near his eye. It responded rapidly to antivirals and there was no pain. The doctor said had he not been vaccinated he could have lost his eye, a complication of shingles when the rash was near the eyes. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
None. HPV vaccine ordered by physician and nurse administered it. The child was 5 yrs old and the vaccine should not have been given, as it is indicated for females 9 and over
Approx 10 min after receiving H1N1 inj. student c/o tingling in both arms vs. WNL, inj site slightly red, no swelling, c/o mild pain. Ice pack applied to site, pursed - lip breathing encouraged. ROM performed both arms. Sx improved & student returned to class. Returned to nurse 2 hrs later - parent notified & will check @ home.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Sep2022 as dose 5 (booster), single (Lot number: GH9694), in right arm and on 16May2023 as dose 6 (booster), single (Lot number: GJ6742) at the age of 72 years, in right arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 13Feb2021 as dose 1, single (Lot number: EL2964), in right arm, on 06Mar2021 as dose 2, single (Lot number: EN6199), in right arm, on 25Sep2021 as dose 3 (booster), single (Lot number: 301308A), in right arm and on 06Apr2022 as dose 4 (booster), single (Lot number: FK9893), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 25Sep2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from Sep2023 to Sep2023.  Clinical course: Bronchospasm unable stop coughing. Never experienced before could only talk short time before spasmodic coughing Bronchitis and fluid in airways crackling noise in chest that can be heard across the room.
Both of my hands went numb and tingled for about 24 hours after I received the Moderna vaccine. It started about 2 hours after I had the vaccine. I did not seek treatment from a doctor. It went away on it's own.